Wrigley
This article was originally published in The Tan Sheet
Executive Summary
Healthcare division has signed a $25 mil. agreement to acquire complete assets of Gum Tech's gum business, firm announces March 15. Under the deal, Wrigley will obtain rights to Gum Tech's manufacturing facility and plant as well as existing manufacturing contracts. Gum Tech will retain its interest in Gel Tech and its joint venture with Swedish Match. Wrigley said the acquisition will enable its new healthcare division to more quickly and cost effectively develop innovative products than it would have by building its own facility. Wrigley Healthcare began shipping Surpass antacid chewing gum, its first OTC product, Feb. 19 (1"The Tan Sheet" Feb. 19, p. 8)
You may also be interested in...
Matrixx Zicam Swabs, Other Extensions Slated For September
Matrixx Initiatives, formerly Gum Tech International, is introducing a novel delivery vehicle to the OTC cough/cold remedy market - Zicam Cold Remedy Swabs
Matrixx Zicam Swabs, Other Extensions Slated For September
Matrixx Initiatives, formerly Gum Tech International, is introducing a novel delivery vehicle to the OTC cough/cold remedy market - Zicam Cold Remedy Swabs
Matrixx Zicam Swabs, Other Extensions Slated For September
Matrixx Initiatives, formerly Gum Tech International, is introducing a novel delivery vehicle to the OTC cough/cold remedy market - Zicam Cold Remedy Swabs